Deutsche Bank Maintains Buy Rating on Select Medical Holdings Corporation
In a recent statement, Deutsche Bank reiterated its Buy rating on Select Medical Holdings Corporation while maintaining a steady price target of $40.00. The analysis conducted by the firm reveals that the market is currently undervaluing Select Medical, with no value attributed to Select RemainCo and the stock priced close to the fair valuation for Concentra SpinCo based on a low-to-mid case scenario.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!